Session 18 · April 2025

Gender Health Gap

What do women lose when diversity disappears from science?

↓ Materials ↓ Session structure

Medical science has a women problem: for decades, drug trials, diagnostic tools, and clinical standards were calibrated on male bodies and male symptoms. This session traced how that systemic bias plays out — in research funding, in pain management, in dismissed diagnoses, and in how Black and brown women face compounded harm from medical racism and misogyny. The timing was deliberate: in early 2025, a wave of US executive orders was defunding the very research that was starting to close these gaps.

Materials
Main
Supplementary
Session structure
  1. The gender health gap — what is it?
    • Drugs dosed for male bodies, conditions presenting differently in women
    • The history of excluding women from clinical trials (fear of hormonal variability, liability)
    • NIH 1993 mandate requiring women's inclusion — and how slowly it has changed practice
  2. Political context: what the 2025 US rollbacks mean
    • HIV programmes terminated, DEI mandates reversed
    • Banned words in research: which bodies disappear from trials?
    • How research gaps become treatment gaps within years
  3. Gynecological violence in the EU
    • Obstetric violence, episiotomies without consent, painful procedures performed without anaesthesia
    • Why women's pain is systematically underestimated
  4. Race and the health gap
    • Black women face compounded harm: medical racism + misogyny
    • Maternal mortality rates by race — the data is stark
    • Conditions on darker skin: what dermatology training misses
  5. Does your doctor's gender matter?
    • Research suggests women have better outcomes with female surgeons
    • What mechanisms explain this?
  6. What can change?
    • Mandatory inclusion of women (and women of colour) in research design
    • How to advocate for yourself in a medical setting

Comments are reviewed by the organisers before appearing here.